TrialSignal
Clinical trial intelligence report
Ovarian Hormones, Reward Response, and Binge Eating in Bulimia Nervosa: An Experimental Design
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT04225221
Status
COMPLETED
Phase
Phase 2
Sponsor
University of North Carolina, Chapel Hill
Executive brief
Investment-Ready Snapshot
This clinical trial investigates the effects of ovarian hormones, specifically estradiol and progesterone, on binge eating behaviors in women diagnosed with bulimia nervosa. The study aims to elucidate the neurobiological mechanisms underlying binge eating and hormone interactions, potentially leading to novel pharmacological treatments for bulimia nervosa.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT04225221
Indication
Bulimia Nervosa
Modality
small molecule
Target
Bulimia Nervosa
Intervention
Estradiol, Micronized progesterone, Leuprolide Acetate, Placebo Oral Capsule
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.